A biomedical company which deals in developing human applications of electroporation, which uses brief, controlled electrical pulses to increase cellular uptake of a useful biopharmaceuticals.
| Current Price | $0.67 | Mkt Cap | $85.12M |
|---|---|---|---|
| Open | $0.66 | P/E Ratio | 0.00 |
| Prev. Close | $0.66 | Div. (Yield) | N/A (N/A) |
| Daily Range | $0.65 - $0.68 | Volume | 213,438 |
| 52-Wk Range | $0.35 - $1.35 | Avg. Daily Vol. | 0 |
| Subject | Recs | Author | Date |
|---|
The best Bull and Bear pitches based on recency and number of recommendations.
For about a year and a half I've been biting away at Inovio with short-term underperforms and doing OK. I'm changing things up a little bit in order to take score leadership away from some red-thumber with a bomb charm. It's a struggle to find… More
I think this company is a scam, everyday they have a press release of some bullsh*t.Usually its we have a cure for aids, or we have the answer for world peace...croc of shi* i tell you
Read the most recent pitches from players about INO.
Recs
ethwc
(35.19)
Submitted: 10/31/2011 5:24:52 PM :
Start Price:
$0.62
INO Score:
-4.06
Pure speculation play. If any one of their present immunization products works out, the company will flourish and a major impact will come about for whichever disease is effected.
Recs
InsiderAlerts
(< 20)
Submitted: 7/3/2011 1:52:24 AM :
Start Price:
$0.57
INO Score:
-0.16
Inovio has several trials going on for DNA vaccines and have already shown some great success. With insiders buying at recent 52 week lows, it appears this stock may be in for a reversal with no end in sight as it gets some fuel on its way up with inevitable phase III trials. A buyout is also possible in it's future as a partnering with Merck is already in play.
Recs
zzlangerhans
(99.30)
Submitted: 5/16/2011 11:52:45 AM :
Start Price:
$0.88
INO Score:
-25.58
For about a year and a half I've been biting away at Inovio with short-term underperforms and doing OK. I'm changing things up a little bit in order to take score leadership away from some red-thumber with a bomb charm.
It's a struggle to find positive things to say about Inovio. They're an uninspiring vaccine developer that hasn't run a phase III trial since the failure of the SECTA electrochemical tumor ablation process in 2007. But the share price is at its lowest point since the summer 2010 market swoon and seems to have stabilized. They have early stage clinical trials of DNA vaccines for HIV, hepatitis C, and avian flu in process as well as a phase II trial of cervical cancer vaccine VGX-3100. I'm not sure their track record justifies a market cap of 100M but given the historical performance of the stock I'll make it a CAPS-only positive for now.
Find the members with the highest scoring picks in INO.
BicaChica (76.24) Score: +107.11
The Score Leader is the player with the highest score across all their picks in INO.
|
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
|---|---|---|---|---|---|---|---|---|---|---|
| BicaChica | 76.24 | 8/3/2009 |
|
5Y | $2.36 | -71.66% | +34.89% | +106.54 | 0 Comment | |
| Longorshort25 | 59.01 | 8/6/2009 |
|
5Y | $2.34 | -71.41% | +34.77% | +106.18 | 0 Comment | |
| epc53 | 93.10 | 7/31/2009 |
|
5Y | $2.12 | -68.45% | +35.83% | +104.28 | 0 Comment | |
| rhinomaj | 91.61 | 8/4/2009 |
|
3M | $2.09 | -68.00% | +34.23% | +102.22 | 0 Comment | |
| guru111melbourne | 75.14 | 11/24/2009 |
|
5Y | $1.55 | -56.85% | +20.79% | +77.64 | 0 Comment | |
| uconn777 | < 20 | 7/1/2010 |
|
5Y | $1.02 | -34.42% | +31.71% | +66.13 | 0 Comment | |
| bdg10 | < 20 | 1/12/2011 |
|
5Y | $1.46 | -54.18% | +4.47% | +58.65 | 0 Comment | |
| hayrettin | 69.46 | 1/24/2012 |
|
5Y | $0.54 | +21.23% | +2.15% | +19.08 | 0 Comment | |
| icebox40 | 91.50 | 1/26/2012 |
|
3W | $0.55 | +19.33% | +1.62% | +17.71 | 0 Comment | |
| rqtect | < 20 | 2/2/2012 |
|
3W | $0.75 | -12.51% | +1.04% | +13.55 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.
| Player Name | Player Rating |
Start Date |
Call | Time Frame |
Start Price |
Stock Gain |
S&P Gain |
Score | End Date | Commentary |
|---|---|---|---|---|---|---|---|---|---|---|
| TrackBreanMurray | 67.25 | 8/3/2010 |
|
NS | $1.05 | -36.30% | +19.20% | -55.50 | 0 Comment | |
| TrackTWeisel | 91.97 | 4/25/2007 |
|
NS | $3.90 | -82.85% | -4.69% | -78.16 | 0 Comment | |
| TrackBWS | 81.56 | 2/27/2007 |
|
NS | $3.25 | -88.31% | -41.36% | -46.94 | 4/23/2009 @ $0.38 | 0 Comment |
